US equities
|
NVDA
$152.19
▼-2.10%
MU
$694.15
▼-2.56%
AMD
$508.14
▲+0.94%
SPCX
$144.72
▲+2.13%
SNDK
$763.56
▼-4.22%
AAPL
$353.28
▲+0.39%
TSLA
$381.57
▲+0.38%
AMZN
$264.47
▲+2.55%
NVDA
$152.19
▼-2.10%
MU
$694.15
▼-2.56%
AMD
$508.14
▲+0.94%
SPCX
$144.72
▲+2.13%
SNDK
$763.56
▼-4.22%
AAPL
$353.28
▲+0.39%
TSLA
$381.57
▲+0.38%
AMZN
$264.47
▲+2.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Orforglipron
Recent news which mentions Orforglipron
Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock
June 13, 2025
Tickers
LLY
Tags
Zepbound
Top Stories
Long Ideas
From
Benzinga
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
Tickers
AMGN
LLY
NVO
Tags
LLY
Orforglipron
Benzinga
From
Benzinga
Ozempic Alternatives: These Two Drugs Show Promise In Affordability And Effectiveness For Weight Loss
July 24, 2023
Tags
obesity
Media
Weight Loss
From
Benzinga